Coronary artery chronic total occlusions (CTO) 
INTRODUCTION
Despite developments in interventional cardiology during the last decade, chronic total occlusions (CTO) still remain as one of the unresolved problems in percutaneous coronary interventions (PCI) (Prasad et al., 2007) . CTO prevalence is high; approximately one-third of patients with significant coronary artery disease on angiography has at least 1 CTO, but only less than 10% of percutaneous revascularisations are CTO interventions (Werner et al., 2009) . CTO PCI is performed infrequently, likely due to historically low procedural success rates, technical complexity, high equipment use and the potential for major procedural complications (Shah, 2011) . Although several studies have shown that successful recanalisation of chronic total occlusion (CTO) of the coronary arteries has been associated with improved survival, improved left ventricular systolic function, reduced angina, avoidance of coronary artery bypass grafting, and increased exercise capacity, the overall benefit of recanalisation of CTO is still limited by the deficiency of prospective randomised trials, properly powered for hard clinical endpoints, comparing contemporary optimal medical therapy with contemporary state of the art CTO recanalisation (Hoye et al., 2005) .
The retrograde approach is a relatively novel technique of PCI for CTO, which allows the advancement of a guide wire in a coronary segment distal to occlusion through collateral vessels. In 1990, the first report of a retrograde approach for CTO was published, in which the retrograde wire crossing technique was applied via a degenerated saphenous vein graft (SVG) (Kahn et al., 1990) . Later septal collaterals were considered to provide potential access for the retrograde approach. In 2005, Katoh and colleagues opened a new era of retrograde CTO recanalisation with the Controlled Antegrade and Retrograde subintimal Tracking (CART) technique (Surmely et al., 2006) . Different kinds of retrograde techniques were introduced in the last years. Novel techniques hold promise in the field of percutaneous coronary intervention for CTO (Saito et al., 2008) .
The first successful retrograde PCI of CTO in Rîga East University Hospital was conducted in January 2007.
The aim of our study was to review 10-year data from a single hospital on CTO PCI experience and compare CTO PCI procedural parameters and treatment results using antegrade and/or retrograde approaches.
MATERIALS AND METHODS
The study included all patients undergoing PCI for CTO at a single tertiary PCI centre during 10 years -between January 2007 and January 2016. A total of 9564 PCI procedures were conducted in this period in our institution. 591 (6.17%) of them were CTO PCI, which was applied for 519 patients. Ten patients had 2 coronary arteries CTOs, for 49 patients more than one CTO PCI attempt was made. The retrograde approach was used for 167 (32.2%) of all CTO PCI patients.
A CTO lesion was defined as an obstruction of a coronary artery with Thrombolysis in Myocardial Infarction (TIMI) flow grade 0 with an estimated duration of at least three months. The duration of the occlusion was determined by the interval from the last episode of acute coronary syndrome consistent with the location of the occlusion or proven by previous angiography.
Indications for performing CTO PCI were at least one of the following: symptoms (angina), positive exercise test, ischemia. PCI was also performed for asymptomatic CTO patients after myocardial infarction in the non CTO area with normal ECG and normal echo findings at CTO related area.
The J-CTO score was used for CTO complexity assessment. This score is the sum of anatomical findings and previous attempt results -predictors of procedure failure: blunt stump, CTO length > 20 mm, presence of severe calcification, proximal segment tortuosity, and previous attempt failure.
An attempt of using the retrograde approach was defined as the introduction of a guide wire into the collateral channels (CCs), which was connecting to the target CTO vessel distal to the lesion. Length of the CTO was measured following bilateral simultaneous coronary injections by visualising the filling of both proximal and distal occluded artery.
Procedural success was defined as a successful guide wire and balloon crossing with residual stenosis < 10% and Thrombolysis in Myocardial Infarction grade 3 flow.
All patients were pretreated with aspirin and clopidogrel. 5000 units of Heparin was used at the beginning of every procedure. Additional 2500 units of Heparin were injected every hour. Activated clotting time (ACT) was not measured. No GP 2B3A receptor blockers used. Both femoral punctures with 6-8 French (Fr) guiding catheter were used commonly. In some cases a radial route was performed together with femoral approach. Only guiding catheters with side holes were used.
The decision and technique used to perform a retrograde attempt was based on operators discretion. If CTO lesion morphology was unfavourable (i.e., blunt stump, ostial location, side branch located exactly at the proximal cap of CTO), with expected low success rate of an antegrade approach, or in a case of unsuccessful antegrade attempt(s) to recanalise a CTO with connecting collaterals filling of the distal part of the target vessel, the retrograde approach was considered as a treatment option. The retrograde approach technique evolved over time with growing operator experience and emergence of dedicated devices.
Patients were separated according to year when PCI was performed, approach (antegrade or retrograde) and PCI results (successful or unsuccessful). Demographic and procedural data were collected at the time of intervention. Inhospital MACE (myocardial infarction, urgent revascularisation, stroke or death) was documented at discharge. Post discharge data was obtained by telephone follow up.
Statistical analysis was performed using IBM SPSS Statistics for Windows, version 22.0. Continuous variables were summarised as mean value ± standard deviation (SD) if normally distributed or as median value and interquartile range (IQR) if data distribution was skewed. Unpaired two-sided t-test and Mann-Whitney U tests were used to compare subgroups. Categorical variables were presented as proportions and subgroups compared by a chi-square test (or chi-square test for trends if applicable). Significance of differences in overall survival between subgroups was tested by KaplanMeier method and log-rank test. A Cox proportional hazard model was used to adjust for potential confounders such as age and sex; the results of the model were presented as hazard ratio (HR) with 95% confidence intervals (CI). A p value less than 0.05 was set to indicate statistically significant differences.
RESULTS
A total of 519 patients undergoing PCI for CTO were included. The median (IQR) age was 64 yrs (38-88), and 80% (415) were male. A retrograde approach (RA) was used for 167 (32.2%) patients. Use of a retrograde approach (RA) increased from 13% in 2007 to 51.3% in 2013 and decreased to 40.5% in 2015 (Fig. 1 , Table 1 ). The overall patient success rate was 81.3% and it increased from 73.9% in 2007 to 95.2% in 2015 (p < 0.001) (Fig. 2) . Table 2 shows baseline demographic and angiographic characteristics of CTO patients.
The target artery with CTO lesions included the left main (two cases, 0.4%) right coronary artery (305 cases, 58.8%), the left anterior descending artery (167 cases, 32.17%), and the left circumflex artery (45 cases, 8.7%). A retrograde approach was used in 36.9% (n = 111) of RCA, 25.9% (n = 43) of LAD and 26.7% (n 12) of LCX cases.
Follow up started on the date of procedure, ended at the day of death or 1 June 2016. Mean patient observation time was 58.7 months (median 60.1 month).
We did not find significant differences in patient clinical characteristics undergoing antegrade and retrograde, successful and unsuccessful procedures, except regarding prior coronary artery bypass grafting (CABG). In the retrograde approach patient group, 23 (13.6%) had previous CABG, compared to 21 (6.0%) of patients in the antegrade group (p = 0.004). Median (IQR) CTO duration was similar in both retrograde and antegrade groups -12 (3-60) and 12 (5-36) months, respectively.
Patients with diabetes (insulin dependent and non-insulin dependent) were 21.1% (n = 74) in the antegrade approach group and 15.4% (n = 26) in the retrograde approach group (p = NS).
The J-CTO score was calculated for all patients: 215 (41.4%) had J CTO score 0 and 263 (50.7%) had score 2-3, and 41 (7.9%) of patients had score 4-5. A retrograde approach was used more frequently in complex cases. For less complex CTO lesions (J-CTO score 0-1), a retrograde approach was used in 7.7% and 19.7% of cases, respectively, for intermediate complex lesions (J-CTO score 2 and 3) in 30.3% and 52.9%, respectively, for very complex lesions (J-CTO score 4) in 70.1% of cases (p < 0.001).
Septal collaterals were more frequently used as the retrograde access route (85.3%), but during the last two years use of epicardial channels has increased.
The main reasons for failure in both groups (antegrade and retrograde) was inability to cross the occlusion with a wire (68.7% of all unsuccessful cases).
The total complication rate was 6.5%: 5.9% in the antegrade patients group and 7.2% (p = 0.630) in the retrograde group.
Kaplan-Meier curves showed better overall survival in the successful procedure group compared to the unsuccessful group (Long-rank test, p = 0.013) (Fig. 3) , but the method used (antegrade or retrograde) did not have any effect on survival (Fig. 4) . In the retrograde procedure group, survival was significantly better (p = 0.019) if the procedure was successful. Similarly, there was a tendency of better survival in the case of success also among patients who underwent an antegrade procedure, albeit it was not statistically significant (p = 0.118) (Figs. 5-6) . 
DISCUSSION
The true prevalence of a CTO in the general population is unknown and not well studied. In a few older studies the prevalence of CTO in patients undergoing coronary angiography ranged between 10% and 52% depending on the clinical profile of the patient being examined. Among patients who underwent coronary angiography because of suspected coronary artery disease, CTO prevalence was 18%, but in patients with angiographically significant coronary artery disease it was 30% (Christofferson, 2005) . CTO prevalence was observed to be higher (54%) among patients with a history of aortocoronary bypass graft (CABG) surgery and lower (10%) among patients with acute coronary syndrome undergoing primary PCI (Fefer, 2012) .
Data from registries reveal striking variability between different centres and countries. For example, in Japanese centres CTO incidence was 19% and 61.2% of these cases were treated percutaneously (Yamamoto et al., 2013) , however in North America, where CTOs are more frequent (29-33%), only between 6% and 9% of patients were treated percutaneously (Srinivas et al., 2002) . In our study the percentage of CTO PCI procedures was low -only 6.2% of all PCI. The number of CTO PCI procedures has decreased during the last years, mainly due to more careful patient selection.
According to definition, CTOs are at least three month old lesions. They are therefore always found in stable chronic patients, with varying levels of symptoms. Patients with acute coronary syndrome occasionally also have a CTO in another, non culprit artery, and is therefore considered a CTO.
Several studies showed that CTO patients are a high-risk population with more traditional cardiovascular risk factors, multivessel disease, history of MI and PCI (Fefer et al., 2012; Grantham et al., 2009 ).
There is no doubt that treatment of CTO affecting an ischemic myocardial area that causes symptoms, such as angina, should improve patient symptoms by providing a greater perfusion flow than that provided by collateral circulation, as a consequence of opening the occluded artery (Werner et al., 2006) . In the FACTOR Trial (Flow Cardia Approach to CTO Recanalization), 125 patients completed the Seattle Angina Questionnaire at baseline and one month after percutaneous coronary intervention (Grantham et al., 2010) . Successful CTO treatment in this trial was associated with an improvement in the frequency of angina, physical capacity and quality of life. However, this improvement was only observed in previously symptomatic patients but not in asymptomatic patients.
If a patient has angina (and therefore ischemia), the benefit of CTO treatment is symptom relief. For patients without angina, but with ischemia, the benefit is not symptomatic and can be evaluated only in prognostic terms (Aziz et al., 2007) . There is not much evidence about the benefit of CTO invasive treatment for non symptomatic patients. The SWISSI II trail conducted in the late 1990s included asymptomatic CTO patients with 1 or 2 coronary artery disease after myocardial infarction and inducible ischemia in an imaging test. The results showed significant reduction of coronary events in the successful CTO PCI group during long-term follow up (Erne et al., 2007) .
The recent Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial, which compared PCI with optimal medical therapy in stable coronary disease, did not show a significant difference in mortality or myocardial infarction between the two treatment options. However, CTOs were not included in the COUR-AGE trial (Boden et al., 2007) .
Some older registries have reported that patients with complete revascularisation have a better prognosis than those with incomplete revascularisation, including the presence of an untreated CTO (Hannan et al., 2006 , Valenti et al., 2008 . The SCAAR (Swedish Coronary Angiography and Angioplasty) Registry includes data from 2006 and 2010 on 23 342 patients with multivessel disease. Incomplete revascularisation (IR) was defined as any non-treated significant (60%) stenosis in a coronary artery supplying 10% of the myocardium. IR at the time of hospital discharge in patients with multivessel disease undergoing PCI was associated with a high risk of recurrent 1-year adverse cardiac events (Hambraeus et al., 2016) .
Although CTO patients are common in clinical work, the evidence for the current guidelines and clinical practice is limited. According to the current European Society of Cardiology (ESC) Revascularisation guidelines, CTO percutaneous revascularisation is considered in patients with myocardial ischemia given myocardial segment and / or symptoms associated with angina (II A, Class B level rec- CTO, chronic total occlusions; PCI, percutaneous coronary interventions ommendation) (Kolh et al., 2014) . A Retrograde approach is recommended as a class IIb recommendation level C, after an unsuccessful antegrade approach or as a starting method for selected patients, without describing this patient group (Kolh et al., 2014) .
In our study indication for CTO PCI was at least one of the following: symptoms (angina), positive exercise test, ischemia. We also performed PCI for asymptomatic CTO patients after myocardial infarction in a non-CTO area with normal ECG and normal echo findings in the CTO-related area. Of course, this does not fully comply with modern understanding about myocardial viability and ischemia, but for several reasons modern myocardial viability examinations in our hospital were not available until 2013 and the main examination given for these patients was an exercise test. Due to better patient selection the number of CTO PCI procedures in our hospital has decreased.
Until 2005, the success rates of operators experienced in conventional CTO percutaneous coronary intervention (PCI) techniques has remained unchanged (60-70%), which is considerably lower than the success rates in nonocclusive coronary artery disease (Ivanhoe et al., 1992) . Many techniques and devices (wires, microcatheters) have been introduced into clinical practice to improve the effectiveness of CTO revascularisation (Sumitsuji et al., 2011) . One of the most important and popular techniques is the retrograde approach, nowadays widely used, and first described in 1990 by Kahn and Hartzler (1990) . The first report of retrograde crossing via septal collaterals was published in 2006, starting the modern era, rapidly evolving with the introduction of specialised equipment (Surmely et al., 2006) .
Vast experience in CTO invasive treatment has been gained in Japan. According to data from the Japan Retrograde Summit registry (Yoshikawa et al., 2013) , use of the retrograde method was 26.6% of all PCI CTO and rate of success has reached 84.8%.
Slightly lower success rates appear in the Euro CTO Club register, which is world's largest. According to the data from this register, during the period from year 2008 to 2012, a retrograde method was used in 16.5% of successful procedures and the success rate reached 75% (Gallassi et al., 2015) .
In our study a retrograde approach was used in 32.2% of cases with success rate 71%, which is comparable with data from Euro CTO Club registry. Use of a retrograde approach has decreased during the last two years, likely due to operator skill improvement and introduction of new technologies for antegrade CTO crossing.
The goal of CTO PCI has always been to make life easier for patients by reducing symptoms and improving prognosis by reducing the number of major cardiovascular events. Multi-register data shows that successfully undergone CTO PCI improves patient prognosis (Mehran, 2011; Joyal, 2010) . In our study, unfortunately, symptom evaluation of patients was not carried out, but, comparing survival after successful and unsuccessful CTO PCI, significantly better results were observed in the successful patient group (Fig.  3) . These results coincide with data obtained in our hospital in 2013 in a shorter observation period (Kalnins et al., 2013) . 
CONCLUSIONS
The main finding of this study was increased survival in patients with successful CTO opening for symptomatic and/or ischemic patients and patients with CTO, but without previous myocardial infarction. Long-term outcome and survival after CTO PCI not only depends on the approach (antegrade or retrograde), but depends on results of the procedure.
